Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$419K Sell
1,192
-31
-3% -$11.1K 0.27% 100
2025
Q4
$400K Sell
1,223
-48
-4% -$15.2K 0.26% 98
2025
Q3
$359K Buy
1,271
+12
+1% +$3.48K 0.2% 119
2025
Q2
$352K Buy
1,259
+39
+3% +$11K 0.23% 110
2025
Q1
$380K Sell
1,220
-30
-2% -$8.86K 0.31% 92
2024
Q4
$326K Buy
+1,250
New +$371K 0.27% 101

Other funds holding AMGN

Leigh Baldwin & Co's AMGN Position: Q1 2026 in Review

Leigh Baldwin & Co reduced its Amgen (AMGN) stake by 2.5% in Q1 2026, selling an estimated $11.1K and leaving 1,192 shares worth $419K. The position accounts for 0.27% of the portfolio, ranked #100.

Leigh Baldwin & Co first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Leigh Baldwin & Co held 1,192 shares of Amgen worth $419K as of Q1 2026.
  • Leigh Baldwin & Co sold 31 Amgen shares in Q1 2026, an estimated $11.1K.
  • Amgen made up 0.27% of Leigh Baldwin & Co's portfolio in Q1 2026, its #100 holding.
  • Leigh Baldwin & Co first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Leigh Baldwin & Co's 13F filing for Q1 2026, filed 20 May 2026.